ResearcherNational Institutes for Quantum Science and TechnologyNo recent work listed
Takashi Imai
Matched on ORCID iD 0000-0002-4318-2241; OpenAlex author ID A5101599251. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper
Papers 3
- Metabolic characterization of invaded cells of the pancreatic cancer cell line, PANC-1. Last author DOI 10.1111/cas.13220↗
- Nitric oxide increases the invasion of pancreatic cancer cells via activation of the PI3K-AKT and RhoA pathways after carbon ion irradiation. Last author DOI 10.1016/j.febslet.2014.07.006↗
- X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and… Last author DOI 10.1111/j.1349-7006.2011.01852.x↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mayumi Fujita · 3 shared papers, 2011–2017 · strength 0.20
- Paper Metabolic characterization of invaded cells of the pancreatic cancer cell line, PANC-1. DOI 10.1111/cas.13220↗
- Paper Nitric oxide increases the invasion of pancreatic cancer cells via activation of the PI3K-AKT and RhoA pathways after c… DOI 10.1016/j.febslet.2014.07.006↗
- Paper X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, M… DOI 10.1111/j.1349-7006.2011.01852.x↗
- Shigeru Yamada · 2 shared papers, 2011–2014 · strength 0.08
- Paper Nitric oxide increases the invasion of pancreatic cancer cells via activation of the PI3K-AKT and RhoA pathways after c… DOI 10.1016/j.febslet.2014.07.006↗
- Paper X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, M… DOI 10.1111/j.1349-7006.2011.01852.x↗
- Satoshi Endo · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.